PankoMab-GEX

Known as: Anti-TA-MUC1 Monoclonal Antibody PankoMab, PankoMab 
A humanized monoclonal antibody recognizing the tumor-specific epitope of mucin-1 (TA-MUC1), with potential antineoplastic activity. Anti-TA-MUC1… (More)

Topic mentions per year

Topic mentions per year

2006-2015
012320062015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND A phase I open-label dose-escalation study was conducted to define the safety, tolerability, and pharmacokinetics (PK… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2016
2016
BACKGROUND During neoplasia, glycosylation changes. In this setting, mucins, especially mucin 1 (MUC1), become carriers for… (More)
Is this relevant?
2015
2015
BACKGROUND Mucin-1 (MUC1, CD227), more widely known as CA15-3, is an abundantly expressed epithelial cell surface antigen and has… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2013
2013
PankoMab-GEX is a novel humanized and glycooptimized antibody, which recognizes a novel specific tumour epitope of MUC1 (TA-MUC1… (More)
Is this relevant?
2012
2012
AIM Mucin 1 (MUC1) is a high molecular weight transmembrane glycoprotein with unique properties which is used as a tumour marker… (More)
Is this relevant?
2010
2010
Humanized antibodies against tumor-related antigens are now established reagents for in vivo diagnostics and for therapeutic… (More)
Is this relevant?
2009
2009
MUC1 (CD227), an established tumor marker, is expressed on glandular epithelia and on epithelial tumors. Tumor MUC1 differs from… (More)
Is this relevant?
2009
2009
AIM PankoMab is a novel antibody that recognizes a tumor-specific epitope of Mucin 1 (MUC1). The aim of this study was the… (More)
  • table 2
  • figure 1
  • table 3
  • figure 2
  • figure 3
Is this relevant?
2009
2009
the following tumor specific glycosylated tandem repeats: PA HGVTSAPDT[GalNAca]RPAPGSTAPPAHGVTSA [6, 7]. The unique features of… (More)
Is this relevant?
2006
2006
Recently, we described a new carbohydrate-induced conformational tumour-epitope on mucin-1 (MUC1) with the potential for… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?